Terumo has not received the device for evaluation, therefore, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.(b)(4).Results: results pending completion of investigation.Conclusions: conclusion not yet available.
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on december 18, 2020.Upon further investigation of the reported event, the following information is new and/or changed: d4 (additional device information - added exp date).G3 (date received by manufacturer).G6 (indication that this is a follow-up report).H2 (follow-up due to additional information).H4 (device manufacture date).H6 (identification of evaluation codes 4747, 2645, 4582, 3331, 4114, 4245, 4308).Component code: 4747 - packaging.Health effect - impact code:2645 - no patient involvement.Health effect - clinical code: 4582 - no clinical signs, symptoms or conditions.Type of investigation #1: 3331 - analysis of production records.Type of investigation #2: 4114 - device not returned.Investigation findings: 4245 - packaging contains incorrect device.Investigation conclusions: 4308 - cause traced to transport/storage.Based on the investigation, the picker person picked in the right location, but the product on that location was not the correct one.The picker did not note and did not used the right equipment to confirm the pick.The root cause was the distribution center picked and sent additional quantity that was not ordered.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|